2021-02-22 16:41:27 BWXT BWX Technologies
02/22/21 02/2216:41 02/22/2116:41 | BWX Technologies sees FY21 EPS $3.05-$3.20, consensus $3.12Sees FY21 revenue growth up low single digits from $2.1B in FY20, consensus $2.15B |
|
---|---|---|
|
Periodicals
|
Fauci predicts resumption of J&J COVID vaccine use, Reuters reports »
17:55 04/18/21 04/1817:55 04/18/2117:55
JNJ
Johnson & Johnson
Anthony Fauci on Sunday… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
TSMC warns trade tensions may disrupt supply, Bloomberg reports »
17:48 04/18/21 04/1817:48 04/18/2117:48
TSM
TSMC
Apple
TSMC (TSM) warned for the… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Amazon cancels Lord of the Rings game announced two years ago, Bloomberg says »
17:40 04/18/21 04/1817:40 04/18/2117:40
AMZN
Amazon.com
Tencent
Amazon's (AMZN)… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Japan, Pfizer agree on more vaccine supply, Bloomberg reports »
17:35 04/18/21 04/1817:35 04/18/2117:35
PFE
Pfizer
Japan's vaccine czar… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Tesla crash in Texas believed to be driverless, WSJ reports »
17:31 04/18/21 04/1817:31 04/18/2117:31
TSLA
Tesla
Two men died after a… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
Evogene to hold a virtual analyst and investor day »
17:24 04/18/21 04/1817:24 04/18/2117:24
EVGN
Evogene
Virtual Analyst and… Story temporarily locked. ShowHide Related Items >><<
|
On The Fly
|
Box Office Battle: 'Godzilla vs. Kong' wins weekend with $7.7M »
17:23 04/18/21 04/1817:23 04/18/2117:23
T
AT&T
Comcast
Comcast
Sony
Lionsgate
Lionsgate
Disney
ViacomCBS
ViacomCBS
"Box Office Battle" is… ShowHide Related Items >><<
|
Conference/Events
|
Advance Auto Parts to hold a virtual meeting »
17:12 04/18/21 04/1817:12 04/18/2117:12
AAP
Advance Auto Parts
Analyst and Investor… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
Morgan Stanley CRE analyst to hold an analyst/industry conference call »
16:46 04/18/21 04/1816:46 04/18/2116:46
Head of US CRE Research… Head of US CRE Research Hill, along with James Woodwell, VP of Mortgage Bankers Association, discuss the state of the Commercial Real Estate Industry on an Analyst/Industry conference call to be held on April 19 at 1 pm. |
Conference/Events
|
Morgan Stanley sustainability analyst holds analyst/industry conference call »
16:33 04/18/21 04/1816:33 04/18/2116:33
Global Head of… Story temporarily locked. |
Conference/Events
|
Morgan Stanley cross-asset strategists hold analyst/industry conference call »
16:30 04/18/21 04/1816:30 04/18/2116:30
Cross-Asset Strategist… Cross-Asset Strategist Sheets, US and European Credit Strategist Sankaran, US IG and Credit Derivatives Strategist Patkar discuss is credit still an early cycle on an Analyst/Industry conference call to be held on April 19 at 9 am. |
Upgrade
|
Sensata upgraded to Outperform from In Line at Evercore ISI »
16:27 04/18/21 04/1816:27 04/18/2116:27
ST
Sensata
Evercore ISI analyst Amit… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
Jefferies alternative energy/solar analyst hold analyst/industry conference call »
16:13 04/18/21 04/1816:13 04/18/2116:13
SPWR
SunPower
First Solar
Renewable Energy
Analysts, along with Cary… Analysts, along with Cary Hayes, Americas President for REC Group, discuss the current state and outlook of the solar market, with a particular focus on solar modules on an Analyst/Industry conference call to be held on April 19 at 10 am. ShowHide Related Items >><<
|
Hot Stocks
|
Prothena presents Phase 1 study results of PRX004 »
16:12 04/18/21 04/1816:12 04/18/2116:12
PRTA
Prothena
Prothena presented… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Elbit Systems awarded $1.65B contract for flight training program »
16:10 04/18/21 04/1816:10 04/18/2116:10
ESLT
Elbit Systems
Elbit Systems announced,… Elbit Systems announced, further to the company's announcement of January 5, 2021, that it was awarded a contract valued at approximately $1.65B for the establishment and operation of the International Flight Training Center of the Hellenic Air Force, as part of an agreement between the Israeli Ministry of Defense and the Hellenic Ministry of National Defense. The contract will be performed over a period of approximately 20 years and will include price indexation. Under the contract, Elbit Systems will supply new M-346 training aircraft and will maintain the entire training fleet, comprised of dozens of M-346 and T-6 training aircraft for a period of approximately 20 years. In addition, the company will provide its latest advanced Embedded Virtual Avionics onboard the training aircraft, deliver networked flight simulators and an array of Ground-Based Training Stations as well as a command and control systems to enable efficient management of the flight training operation. ShowHide Related Items >><<
|
Hot Stocks
|
CNH Industrial terminates On-Highway business discussions with FAW Jiefang »
16:08 04/18/21 04/1816:08 04/18/2116:08
CNHI
CNH Industrial
CNH Industrial has… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Amarin presents new analyses of EVAPORATE study »
16:06 04/18/21 04/1816:06 04/18/2116:06
AMRN
Amarin
Amarin announced that… Amarin announced that further analyses from the Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients with Elevated Triglycerides on Statin Therapy: EVAPORATE Trial were presented as Late-Breaking Science at European Society of Cardiology Preventive Cardiology 2021, the Annual Congress of the European Association of Preventive Cardiology, on April 17. As previously reported and published in the European Heart Journal, VASCEPA demonstrated significant, 17% regression of low attenuation plaque volume on multidetector computed tomography compared with placebo over 18 months. The Effect of Icosapent Ethyl on Changes in Coronary Plaque Morphology: EVAPORATE analyses presented at ESC Preventive Cardiology 2021 demonstrated that with administration of 4 g/day of VASCEPA on top of statin therapy, there was an observed change in plaque stability occurring at 9 months and sustained through 18 months. Of the 80 patients that were enrolled in the randomized, double-blind, placebo-controlled EVAPORATE trial, 55 patients had images that were able to be utilized for the histology-validated software. The EVAPORATE plaque morphology study used ElucidVivo, the first FDA-cleared analysis for specific tissue characterization using histopathologic correlates to assess plaque morphology characteristics, including Lipid Rich Necrotic Core, fibrous cap thickness, and intraplaque hemorrhage. Whereas with placebo LRNC increased and cap thickness decreased, both indicative of moving to a less stable phenotype, with icosapent ethyl there was a measured LRNC decrease and cap thickness increase, indicative of moving to a more stable phenotype. The primary limitation of this single coronary plaque study as identified by its investigators is its small sample size. More study is needed to more fully understand the effects of VASCEPA on coronary plaque to determine the relationship, if any, of such plaque effects on cardiovascular risk reduction. ShowHide Related Items >><<
|
Hot Stocks
|
Peloton refutes consumer product safety commission claims »
16:02 04/18/21 04/1816:02 04/18/2116:02
PTON
Peloton
In a statement, Peloton… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Avadel presents new data from pivotal REST-ON Phase 3 trial of FT218 »
15:59 04/18/21 04/1815:59 04/18/2115:59
AVDL
Avadel Pharmaceuticals
Avadel Pharmaceuticals… Avadel Pharmaceuticals announced the presentation of positive secondary endpoint data at the 2021 American Academy of Neurology Annual Meeting being held virtually from April 17-22, 2021. FT218 is currently under review at the U.S. Food and Drug Administration with a Prescription Drug User Fee Act target date of October 15, 2021. FT218 demonstrated significant consolidation of sleep on polysomnography for the 6 g dose at Week 3, the 7.5 g dose at Week 8, and 9 g dose at Week 13 compared to placebo. Data from the randomized, double-blind, placebo-controlled, multicenter, parallel-group study showed that the mean difference between FT218 and placebo for disturbed nocturnal sleep was statistically significant at all doses tested. FT218 was generally well tolerated, and the most common adverse reactions were well-known and established sodium oxybate adverse reactions. Daytime Sleepiness, Sleep Quality, Hallucinations, and Sleep Paralysis in Patients with Narcolepsy: Additionally, FT218 demonstrated significant improvement in the Epworth Sleepiness Scale versus placebo at all doses tested. FT218 showed a statistically significant improvement compared to placebo at all doses tested for sleep quality and refreshing nature of sleep on a visual analogue scale, and for sleep paralysis on a sleep symptom diary. FT218 did not demonstrate significant improvement for hypnagogic compared to placebo. Adverse events were similar to the known sodium oxybate safety profile. ShowHide Related Items >><<
|
On The Fly
|
On the Fly: The Week in SPAC News »
07:45 04/18/21 04/1807:45 04/18/2107:45
AGC
Altimeter Growth
Grab
Consonance-HFW Acquisition
D8 Holdings Corp.
Computer Motion Inc
D and Z Media Acquisition
IntercontinentalExchange
TCV Acquisition
TPG Pace Beneficial II
In SPAC news this week,… ShowHide Related Items >><<
|
On The Fly
|
On the Fly: The Short Interest Report »
19:18 04/17/21 04/1719:18 04/17/2119:18
IWF
iShares Russell 1000 Growth
iShares Russell 1000 Value
Stitch Fix
Bed Bath & Beyond
Root
Second Sight
SunPower
Welcome to the inaugural… ShowHide Related Items >><<
|
Hot Stocks
|
Tesla CEO sees 'limited production of Model Y this year' at 'Giga Texas' factory »
19:02 04/17/21 04/1719:02 04/17/2119:02
TSLA
Tesla
In a reply to a tweet… In a reply to a tweet inquiring about the status of Tesla's "Giga Texas" factory progress, Tesla CEO Elon Musk stated he sees "Limited production of Model Y this year, high volume next year". In a follow-up reply regarding the company's factory in Germany, Musk added: "Same with Berlin". Reference Link ShowHide Related Items >><<
|
Hot Stocks
|
U.S. safety agency tells consumers to stop using new Peloton treadmill »
14:19 04/17/21 04/1714:19 04/17/2114:19
PTON
Peloton
The U.S. Consumer Product… The U.S. Consumer Product Safety Commission issued a bulletin today about the "danger of popular Peloton Tread+ exercise machine after multiple incidents of small children and a pet being injured beneath the machines. The Commission has found that the public health and safety requires this notice to warn the public quickly of the hazard." The warning comes less than a month after Peloton itself released news of a child's death by a Peloton Tread+. The agency is continuing to investigate all known incidents of injury or death related to the Peloton Tread+. To date, CPSC is aware of 39 incidents including one death. CPSC staff believes the Peloton Tread+ "poses serious risks to children for abrasions, fractures, and death." It added, "In light of multiple reports of children becoming entrapped, pinned, and pulled under the rear roller of the product, CPSC urges consumers with children at home to stop using the product immediately." Reference Link ShowHide Related Items >><<
|
Periodicals
|
Coinbase 'the best way' to play bitcoin boom, Barron's says »
11:11 04/17/21 04/1711:11 04/17/2111:11
COIN
Coinbase
Bitcoin
Coinbase Global issued… Coinbase Global issued stock at an ideal moment-the value of the cryptocurrency market has doubled in just the past two months, Bitcoin is booming, and institutional investors are scrambling to get in, Avi Salzman writes in this week's edition of Barron's. Coinbase is "the real deal," a novel company with competitive advantages that have enabled it to increase market share despite fierce rivals, the author contends. The stock may falter in the next crypto downturn, but its current valuation does not look unreasonable, Salzman says, adding that there is good reason to believe the stock could rise significantly. Reference Link ShowHide Related Items >><<
|
Periodicals
|
O'Reilly Automotive stock should be a winner, Barron's says »
11:07 04/17/21 04/1711:07 04/17/2111:07
ORLY
O'Reilly Automotive
With the U.S. tiptoeing… With the U.S. tiptoeing toward the end of the lockdowns, people will be driving more than they have in the past year, for work and for play, and O'Reilly Automotive stock should be one winner, Teresa Rivas writes in this week's edition of Barron's. The company has used the downtime caused by the pandemic to improve its business and gain market share, while expanding its bricks-and-mortar footprint, the author notes, adding that work should pay off in the months ahead as life continues to return to something like normal. Reference Link ShowHide Related Items >><<
|